Kronos Bio, Inc.
Kronos Bio, Inc. KRON Peers
See (KRON) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KRON | $0.73 | -1.84% | 44.29M | -0.51 | -$1.43 | N/A |
| VRTX | $432.00 | -1.68% | 110.94B | -112.79 | -$3.83 | N/A |
| REGN | $574.16 | -0.26% | 60.95B | 14.60 | $39.32 | +0.15% |
| SGEN | $228.74 | -0.07% | 43.15B | -57.19 | -$4.00 | N/A |
| ALNY | $266.86 | -1.23% | 34.80B | -127.08 | -$2.10 | N/A |
| ARGX | $542.47 | -3.29% | 33.12B | 42.48 | $12.77 | N/A |
| BNTX | $94.50 | -2.85% | 22.72B | -26.18 | -$3.61 | N/A |
| BGNE | $184.71 | +0.49% | 20.21B | -22.55 | -$8.19 | N/A |
| RPRX | $32.82 | -1.59% | 18.85B | 17.18 | $1.91 | +2.59% |
| DNA-WT | $0.27 | -2.76% | 18.73B | N/A | N/A | N/A |
Stock Comparison
KRON vs VRTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, VRTX has a market cap of 110.94B. Regarding current trading prices, KRON is priced at $0.73, while VRTX trades at $432.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas VRTX's P/E ratio is -112.79. In terms of profitability, KRON's ROE is -0.64%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, KRON is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs REGN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, REGN has a market cap of 60.95B. Regarding current trading prices, KRON is priced at $0.73, while REGN trades at $574.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas REGN's P/E ratio is 14.60. In terms of profitability, KRON's ROE is -0.64%, compared to REGN's ROE of +0.15%. Regarding short-term risk, KRON is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs SGEN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, SGEN has a market cap of 43.15B. Regarding current trading prices, KRON is priced at $0.73, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas SGEN's P/E ratio is -57.19. In terms of profitability, KRON's ROE is -0.64%, compared to SGEN's ROE of -0.17%. Regarding short-term risk, KRON is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ALNY Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ALNY has a market cap of 34.80B. Regarding current trading prices, KRON is priced at $0.73, while ALNY trades at $266.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ALNY's P/E ratio is -127.08. In terms of profitability, KRON's ROE is -0.64%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, KRON is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ARGX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ARGX has a market cap of 33.12B. Regarding current trading prices, KRON is priced at $0.73, while ARGX trades at $542.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ARGX's P/E ratio is 42.48. In terms of profitability, KRON's ROE is -0.64%, compared to ARGX's ROE of +0.16%. Regarding short-term risk, KRON is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs BNTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BNTX has a market cap of 22.72B. Regarding current trading prices, KRON is priced at $0.73, while BNTX trades at $94.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BNTX's P/E ratio is -26.18. In terms of profitability, KRON's ROE is -0.64%, compared to BNTX's ROE of -0.03%. Regarding short-term risk, KRON is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs BGNE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BGNE has a market cap of 20.21B. Regarding current trading prices, KRON is priced at $0.73, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BGNE's P/E ratio is -22.55. In terms of profitability, KRON's ROE is -0.64%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, KRON is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs RPRX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RPRX has a market cap of 18.85B. Regarding current trading prices, KRON is priced at $0.73, while RPRX trades at $32.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RPRX's P/E ratio is 17.18. In terms of profitability, KRON's ROE is -0.64%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, KRON is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs DNA-WT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, DNA-WT has a market cap of 18.73B. Regarding current trading prices, KRON is priced at $0.73, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, KRON's ROE is -0.64%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, KRON is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs SMMT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, SMMT has a market cap of 18.15B. Regarding current trading prices, KRON is priced at $0.73, while SMMT trades at $24.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas SMMT's P/E ratio is -72.38. In terms of profitability, KRON's ROE is -0.64%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, KRON is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs UTHR Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, UTHR has a market cap of 13.90B. Regarding current trading prices, KRON is priced at $0.73, while UTHR trades at $308.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas UTHR's P/E ratio is 12.27. In terms of profitability, KRON's ROE is -0.64%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, KRON is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs KRTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, KRTX has a market cap of 12.60B. Regarding current trading prices, KRON is priced at $0.73, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas KRTX's P/E ratio is -28.09. In terms of profitability, KRON's ROE is -0.64%, compared to KRTX's ROE of -0.25%. Regarding short-term risk, KRON is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs GMAB Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, GMAB has a market cap of 12.09B. Regarding current trading prices, KRON is priced at $0.73, while GMAB trades at $19.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas GMAB's P/E ratio is 10.49. In terms of profitability, KRON's ROE is -0.64%, compared to GMAB's ROE of +0.24%. Regarding short-term risk, KRON is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs INCY Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, INCY has a market cap of 11.77B. Regarding current trading prices, KRON is priced at $0.73, while INCY trades at $60.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas INCY's P/E ratio is 304.05. In terms of profitability, KRON's ROE is -0.64%, compared to INCY's ROE of +0.01%. Regarding short-term risk, KRON is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs BMRN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BMRN has a market cap of 11.46B. Regarding current trading prices, KRON is priced at $0.73, while BMRN trades at $59.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BMRN's P/E ratio is 22.14. In terms of profitability, KRON's ROE is -0.64%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, KRON is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs EXEL Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, EXEL has a market cap of 10.18B. Regarding current trading prices, KRON is priced at $0.73, while EXEL trades at $36.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas EXEL's P/E ratio is 20.99. In terms of profitability, KRON's ROE is -0.64%, compared to EXEL's ROE of +0.24%. Regarding short-term risk, KRON is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MRNA Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MRNA has a market cap of 9.86B. Regarding current trading prices, KRON is priced at $0.73, while MRNA trades at $25.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MRNA's P/E ratio is -2.92. In terms of profitability, KRON's ROE is -0.64%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, KRON is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ASND Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ASND has a market cap of 9.75B. Regarding current trading prices, KRON is priced at $0.73, while ASND trades at $161.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ASND's P/E ratio is -24.58. In terms of profitability, KRON's ROE is -0.64%, compared to ASND's ROE of +1.91%. Regarding short-term risk, KRON is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs RXDX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RXDX has a market cap of 9.56B. Regarding current trading prices, KRON is priced at $0.73, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RXDX's P/E ratio is -56.47. In terms of profitability, KRON's ROE is -0.64%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, KRON is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs IMGN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, IMGN has a market cap of 8.73B. Regarding current trading prices, KRON is priced at $0.73, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas IMGN's P/E ratio is -111.55. In terms of profitability, KRON's ROE is -0.64%, compared to IMGN's ROE of +0.05%. Regarding short-term risk, KRON is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs CERE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CERE has a market cap of 8.19B. Regarding current trading prices, KRON is priced at $0.73, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CERE's P/E ratio is -16.47. In terms of profitability, KRON's ROE is -0.64%, compared to CERE's ROE of -0.99%. Regarding short-term risk, KRON is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs TECH Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, TECH has a market cap of 8.09B. Regarding current trading prices, KRON is priced at $0.73, while TECH trades at $51.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas TECH's P/E ratio is 62.18. In terms of profitability, KRON's ROE is -0.64%, compared to TECH's ROE of +0.06%. Regarding short-term risk, KRON is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs ROIVW Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ROIVW has a market cap of 7.83B. Regarding current trading prices, KRON is priced at $0.73, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, KRON's ROE is -0.64%, compared to ROIVW's ROE of -0.02%. Regarding short-term risk, KRON is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs ROIV Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ROIV has a market cap of 7.68B. Regarding current trading prices, KRON is priced at $0.73, while ROIV trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ROIV's P/E ratio is -10.76. In terms of profitability, KRON's ROE is -0.64%, compared to ROIV's ROE of -0.02%. Regarding short-term risk, KRON is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs CORT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CORT has a market cap of 7.49B. Regarding current trading prices, KRON is priced at $0.73, while CORT trades at $70.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CORT's P/E ratio is 61.38. In terms of profitability, KRON's ROE is -0.64%, compared to CORT's ROE of +0.20%. Regarding short-term risk, KRON is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs RVMD Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RVMD has a market cap of 7.44B. Regarding current trading prices, KRON is priced at $0.73, while RVMD trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RVMD's P/E ratio is -11.16. In terms of profitability, KRON's ROE is -0.64%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, KRON is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs RETA Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RETA has a market cap of 6.57B. Regarding current trading prices, KRON is priced at $0.73, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RETA's P/E ratio is -66.29. In terms of profitability, KRON's ROE is -0.64%, compared to RETA's ROE of +0.47%. Regarding short-term risk, KRON is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MDGL Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MDGL has a market cap of 6.56B. Regarding current trading prices, KRON is priced at $0.73, while MDGL trades at $295.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MDGL's P/E ratio is -16.56. In terms of profitability, KRON's ROE is -0.64%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, KRON is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs BPMC Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BPMC has a market cap of 6.42B. Regarding current trading prices, KRON is priced at $0.73, while BPMC trades at $99.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BPMC's P/E ratio is -39.60. In terms of profitability, KRON's ROE is -0.64%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, KRON is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs JAZZ Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, JAZZ has a market cap of 6.34B. Regarding current trading prices, KRON is priced at $0.73, while JAZZ trades at $102.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas JAZZ's P/E ratio is 13.98. In terms of profitability, KRON's ROE is -0.64%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, KRON is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs BBIO Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BBIO has a market cap of 6.32B. Regarding current trading prices, KRON is priced at $0.73, while BBIO trades at $33.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BBIO's P/E ratio is -9.34. In terms of profitability, KRON's ROE is -0.64%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, KRON is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs HALO Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, HALO has a market cap of 6.19B. Regarding current trading prices, KRON is priced at $0.73, while HALO trades at $50.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas HALO's P/E ratio is 13.36. In terms of profitability, KRON's ROE is -0.64%, compared to HALO's ROE of +1.22%. Regarding short-term risk, KRON is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs VRNA Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, VRNA has a market cap of 5.75B. Regarding current trading prices, KRON is priced at $0.73, while VRNA trades at $67.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas VRNA's P/E ratio is -33.78. In terms of profitability, KRON's ROE is -0.64%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, KRON is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs TLX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, TLX has a market cap of 5.59B. Regarding current trading prices, KRON is priced at $0.73, while TLX trades at $16.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas TLX's P/E ratio is 185.67. In terms of profitability, KRON's ROE is -0.64%, compared to TLX's ROE of +0.14%. Regarding short-term risk, KRON is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ABCM Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ABCM has a market cap of 5.52B. Regarding current trading prices, KRON is priced at $0.73, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, KRON's ROE is -0.64%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, KRON is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ISEE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ISEE has a market cap of 5.51B. Regarding current trading prices, KRON is priced at $0.73, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ISEE's P/E ratio is -22.44. In terms of profitability, KRON's ROE is -0.64%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, KRON is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs TGTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, TGTX has a market cap of 5.30B. Regarding current trading prices, KRON is priced at $0.73, while TGTX trades at $33.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas TGTX's P/E ratio is 133.48. In terms of profitability, KRON's ROE is -0.64%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, KRON is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs AXSM Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, AXSM has a market cap of 5.20B. Regarding current trading prices, KRON is priced at $0.73, while AXSM trades at $105.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas AXSM's P/E ratio is -18.35. In terms of profitability, KRON's ROE is -0.64%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, KRON is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs IONS Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, IONS has a market cap of 5.18B. Regarding current trading prices, KRON is priced at $0.73, while IONS trades at $32.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas IONS's P/E ratio is -10.88. In terms of profitability, KRON's ROE is -0.64%, compared to IONS's ROE of -0.00%. Regarding short-term risk, KRON is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs NUVL Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, NUVL has a market cap of 5.13B. Regarding current trading prices, KRON is priced at $0.73, while NUVL trades at $71.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas NUVL's P/E ratio is -18.17. In terms of profitability, KRON's ROE is -0.64%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, KRON is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs ALKS Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ALKS has a market cap of 5.09B. Regarding current trading prices, KRON is priced at $0.73, while ALKS trades at $30.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ALKS's P/E ratio is 14.69. In terms of profitability, KRON's ROE is -0.64%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, KRON is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ADMA Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ADMA has a market cap of 4.75B. Regarding current trading prices, KRON is priced at $0.73, while ADMA trades at $19.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ADMA's P/E ratio is 24.54. In terms of profitability, KRON's ROE is -0.64%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, KRON is less volatile compared to ADMA. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs ALPN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ALPN has a market cap of 4.46B. Regarding current trading prices, KRON is priced at $0.73, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ALPN's P/E ratio is -101.52. In terms of profitability, KRON's ROE is -0.64%, compared to ALPN's ROE of -0.15%. Regarding short-term risk, KRON is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs OPT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, OPT has a market cap of 4.20B. Regarding current trading prices, KRON is priced at $0.73, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas OPT's P/E ratio is -1.52. In terms of profitability, KRON's ROE is -0.64%, compared to OPT's ROE of +2.60%. Regarding short-term risk, KRON is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MRTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MRTX has a market cap of 4.12B. Regarding current trading prices, KRON is priced at $0.73, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MRTX's P/E ratio is -4.82. In terms of profitability, KRON's ROE is -0.64%, compared to MRTX's ROE of -0.40%. Regarding short-term risk, KRON is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs KRYS Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, KRYS has a market cap of 3.89B. Regarding current trading prices, KRON is priced at $0.73, while KRYS trades at $134.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas KRYS's P/E ratio is 32.26. In terms of profitability, KRON's ROE is -0.64%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, KRON is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs PCVX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, PCVX has a market cap of 3.88B. Regarding current trading prices, KRON is priced at $0.73, while PCVX trades at $30.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas PCVX's P/E ratio is -7.91. In terms of profitability, KRON's ROE is -0.64%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, KRON is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs RYZB Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RYZB has a market cap of 3.75B. Regarding current trading prices, KRON is priced at $0.73, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RYZB's P/E ratio is -57.86. In terms of profitability, KRON's ROE is -0.64%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, KRON is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs CBAY Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CBAY has a market cap of 3.73B. Regarding current trading prices, KRON is priced at $0.73, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CBAY's P/E ratio is -32.81. In terms of profitability, KRON's ROE is -0.64%, compared to CBAY's ROE of -0.32%. Regarding short-term risk, KRON is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs PTCT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, PTCT has a market cap of 3.68B. Regarding current trading prices, KRON is priced at $0.73, while PTCT trades at $46.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas PTCT's P/E ratio is 7.13. In terms of profitability, KRON's ROE is -0.64%, compared to PTCT's ROE of +0.36%. Regarding short-term risk, KRON is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs CYTK Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CYTK has a market cap of 3.66B. Regarding current trading prices, KRON is priced at $0.73, while CYTK trades at $30.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CYTK's P/E ratio is -5.79. In terms of profitability, KRON's ROE is -0.64%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, KRON is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs RYTM Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RYTM has a market cap of 3.61B. Regarding current trading prices, KRON is priced at $0.73, while RYTM trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RYTM's P/E ratio is -13.09. In terms of profitability, KRON's ROE is -0.64%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, KRON is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs RNA Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RNA has a market cap of 3.60B. Regarding current trading prices, KRON is priced at $0.73, while RNA trades at $29.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RNA's P/E ratio is -10.34. In terms of profitability, KRON's ROE is -0.64%, compared to RNA's ROE of -0.26%. Regarding short-term risk, KRON is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs SRPT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, SRPT has a market cap of 3.56B. Regarding current trading prices, KRON is priced at $0.73, while SRPT trades at $36.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas SRPT's P/E ratio is -13.71. In terms of profitability, KRON's ROE is -0.64%, compared to SRPT's ROE of +0.20%. Regarding short-term risk, KRON is less volatile compared to SRPT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs SWTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, SWTX has a market cap of 3.48B. Regarding current trading prices, KRON is priced at $0.73, while SWTX trades at $46.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas SWTX's P/E ratio is -13.28. In terms of profitability, KRON's ROE is -0.64%, compared to SWTX's ROE of -0.48%. Regarding short-term risk, KRON is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs RARE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, RARE has a market cap of 3.35B. Regarding current trading prices, KRON is priced at $0.73, while RARE trades at $35.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas RARE's P/E ratio is -5.63. In terms of profitability, KRON's ROE is -0.64%, compared to RARE's ROE of -1.86%. Regarding short-term risk, KRON is more volatile compared to RARE. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs CRSP Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CRSP has a market cap of 3.21B. Regarding current trading prices, KRON is priced at $0.73, while CRSP trades at $37.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CRSP's P/E ratio is -8.58. In terms of profitability, KRON's ROE is -0.64%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, KRON is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs ACLX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ACLX has a market cap of 3.21B. Regarding current trading prices, KRON is priced at $0.73, while ACLX trades at $58.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ACLX's P/E ratio is -29.12. In terms of profitability, KRON's ROE is -0.64%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, KRON is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs SLNO Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, SLNO has a market cap of 3.21B. Regarding current trading prices, KRON is priced at $0.73, while SLNO trades at $69.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas SLNO's P/E ratio is -15.97. In terms of profitability, KRON's ROE is -0.64%, compared to SLNO's ROE of -0.75%. Regarding short-term risk, KRON is less volatile compared to SLNO. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs AKRO Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, AKRO has a market cap of 3.19B. Regarding current trading prices, KRON is priced at $0.73, while AKRO trades at $40.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas AKRO's P/E ratio is -10.67. In terms of profitability, KRON's ROE is -0.64%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, KRON is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs VKTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, VKTX has a market cap of 3.11B. Regarding current trading prices, KRON is priced at $0.73, while VKTX trades at $27.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas VKTX's P/E ratio is -23.91. In terms of profitability, KRON's ROE is -0.64%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, KRON is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs SRRK Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, SRRK has a market cap of 2.98B. Regarding current trading prices, KRON is priced at $0.73, while SRRK trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas SRRK's P/E ratio is -12.71. In terms of profitability, KRON's ROE is -0.64%, compared to SRRK's ROE of -1.29%. Regarding short-term risk, KRON is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs CRNX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CRNX has a market cap of 2.90B. Regarding current trading prices, KRON is priced at $0.73, while CRNX trades at $30.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CRNX's P/E ratio is -8.39. In terms of profitability, KRON's ROE is -0.64%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, KRON is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs CPRX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CPRX has a market cap of 2.88B. Regarding current trading prices, KRON is priced at $0.73, while CPRX trades at $23.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CPRX's P/E ratio is 18.05. In terms of profitability, KRON's ROE is -0.64%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, KRON is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs ACAD Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ACAD has a market cap of 2.88B. Regarding current trading prices, KRON is priced at $0.73, while ACAD trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ACAD's P/E ratio is 12.65. In terms of profitability, KRON's ROE is -0.64%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, KRON is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MORF Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MORF has a market cap of 2.86B. Regarding current trading prices, KRON is priced at $0.73, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MORF's P/E ratio is -14.88. In terms of profitability, KRON's ROE is -0.64%, compared to MORF's ROE of -0.27%. Regarding short-term risk, KRON is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MOR Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MOR has a market cap of 2.86B. Regarding current trading prices, KRON is priced at $0.73, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MOR's P/E ratio is -12.64. In terms of profitability, KRON's ROE is -0.64%, compared to MOR's ROE of +7.43%. Regarding short-term risk, KRON is less volatile compared to MOR. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs LEGN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, LEGN has a market cap of 2.85B. Regarding current trading prices, KRON is priced at $0.73, while LEGN trades at $31.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas LEGN's P/E ratio is -32.37. In terms of profitability, KRON's ROE is -0.64%, compared to LEGN's ROE of -0.16%. Regarding short-term risk, KRON is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs MRUS Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MRUS has a market cap of 2.83B. Regarding current trading prices, KRON is priced at $0.73, while MRUS trades at $40.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MRUS's P/E ratio is -12.21. In terms of profitability, KRON's ROE is -0.64%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, KRON is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs PTGX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, PTGX has a market cap of 2.74B. Regarding current trading prices, KRON is priced at $0.73, while PTGX trades at $44.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas PTGX's P/E ratio is 56.76. In terms of profitability, KRON's ROE is -0.64%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, KRON is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs MTSR Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MTSR has a market cap of 2.74B. Regarding current trading prices, KRON is priced at $0.73, while MTSR trades at $26.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MTSR's P/E ratio is -12.86. In terms of profitability, KRON's ROE is -0.64%, compared to MTSR's ROE of -0.55%. Regarding short-term risk, KRON is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs KDNY Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, KDNY has a market cap of 2.71B. Regarding current trading prices, KRON is priced at $0.73, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas KDNY's P/E ratio is -12.47. In terms of profitability, KRON's ROE is -0.64%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, KRON is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MYOV Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MYOV has a market cap of 2.62B. Regarding current trading prices, KRON is priced at $0.73, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MYOV's P/E ratio is -14.05. In terms of profitability, KRON's ROE is -0.64%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, KRON is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs MLTX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MLTX has a market cap of 2.45B. Regarding current trading prices, KRON is priced at $0.73, while MLTX trades at $38.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MLTX's P/E ratio is -20.39. In terms of profitability, KRON's ROE is -0.64%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, KRON is less volatile compared to MLTX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs IMVT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, IMVT has a market cap of 2.38B. Regarding current trading prices, KRON is priced at $0.73, while IMVT trades at $14.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas IMVT's P/E ratio is -5.35. In terms of profitability, KRON's ROE is -0.64%, compared to IMVT's ROE of -0.78%. Regarding short-term risk, KRON is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs PRVB Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, PRVB has a market cap of 2.38B. Regarding current trading prices, KRON is priced at $0.73, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas PRVB's P/E ratio is -16.43. In terms of profitability, KRON's ROE is -0.64%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, KRON is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs LBPH Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, LBPH has a market cap of 2.34B. Regarding current trading prices, KRON is priced at $0.73, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas LBPH's P/E ratio is -26.66. In terms of profitability, KRON's ROE is -0.64%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, KRON is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs APGE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, APGE has a market cap of 2.32B. Regarding current trading prices, KRON is priced at $0.73, while APGE trades at $39.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas APGE's P/E ratio is -12.04. In terms of profitability, KRON's ROE is -0.64%, compared to APGE's ROE of -0.19%. Regarding short-term risk, KRON is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs VCYT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, VCYT has a market cap of 2.30B. Regarding current trading prices, KRON is priced at $0.73, while VCYT trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas VCYT's P/E ratio is 94.55. In terms of profitability, KRON's ROE is -0.64%, compared to VCYT's ROE of +0.02%. Regarding short-term risk, KRON is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs DICE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, DICE has a market cap of 2.27B. Regarding current trading prices, KRON is priced at $0.73, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas DICE's P/E ratio is -21.91. In terms of profitability, KRON's ROE is -0.64%, compared to DICE's ROE of +0.56%. Regarding short-term risk, KRON is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs XENE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, XENE has a market cap of 2.27B. Regarding current trading prices, KRON is priced at $0.73, while XENE trades at $29.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas XENE's P/E ratio is -9.83. In terms of profitability, KRON's ROE is -0.64%, compared to XENE's ROE of -0.32%. Regarding short-term risk, KRON is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs MIRM Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, MIRM has a market cap of 2.24B. Regarding current trading prices, KRON is priced at $0.73, while MIRM trades at $45.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas MIRM's P/E ratio is -24.47. In terms of profitability, KRON's ROE is -0.64%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, KRON is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs IBRX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, IBRX has a market cap of 2.22B. Regarding current trading prices, KRON is priced at $0.73, while IBRX trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas IBRX's P/E ratio is -4.05. In terms of profitability, KRON's ROE is -0.64%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, KRON is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs VCEL Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, VCEL has a market cap of 2.20B. Regarding current trading prices, KRON is priced at $0.73, while VCEL trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas VCEL's P/E ratio is 218.20. In terms of profitability, KRON's ROE is -0.64%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, KRON is less volatile compared to VCEL. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs APLS Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, APLS has a market cap of 2.17B. Regarding current trading prices, KRON is priced at $0.73, while APLS trades at $17.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas APLS's P/E ratio is -10.80. In terms of profitability, KRON's ROE is -0.64%, compared to APLS's ROE of -1.00%. Regarding short-term risk, KRON is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs CALT Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, CALT has a market cap of 2.15B. Regarding current trading prices, KRON is priced at $0.73, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas CALT's P/E ratio is -22.73. In terms of profitability, KRON's ROE is -0.64%, compared to CALT's ROE of -2.10%. Regarding short-term risk, KRON is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs NAMS Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, NAMS has a market cap of 2.11B. Regarding current trading prices, KRON is priced at $0.73, while NAMS trades at $18.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas NAMS's P/E ratio is -7.32. In terms of profitability, KRON's ROE is -0.64%, compared to NAMS's ROE of -0.26%. Regarding short-term risk, KRON is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs BCRX Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BCRX has a market cap of 2.11B. Regarding current trading prices, KRON is priced at $0.73, while BCRX trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BCRX's P/E ratio is -38.69. In terms of profitability, KRON's ROE is -0.64%, compared to BCRX's ROE of +0.15%. Regarding short-term risk, KRON is less volatile compared to BCRX. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs ARWR Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, ARWR has a market cap of 2.10B. Regarding current trading prices, KRON is priced at $0.73, while ARWR trades at $15.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas ARWR's P/E ratio is -2.97. In terms of profitability, KRON's ROE is -0.64%, compared to ARWR's ROE of -0.46%. Regarding short-term risk, KRON is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs AAPG Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, AAPG has a market cap of 2.09B. Regarding current trading prices, KRON is priced at $0.73, while AAPG trades at $24.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas AAPG's P/E ratio is -32.49. In terms of profitability, KRON's ROE is -0.64%, compared to AAPG's ROE of N/A. Regarding short-term risk, KRON is less volatile compared to AAPG. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs DNLI Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, DNLI has a market cap of 2.07B. Regarding current trading prices, KRON is priced at $0.73, while DNLI trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas DNLI's P/E ratio is -5.34. In terms of profitability, KRON's ROE is -0.64%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, KRON is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs LGND Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, LGND has a market cap of 2.04B. Regarding current trading prices, KRON is priced at $0.73, while LGND trades at $105.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas LGND's P/E ratio is -480.14. In terms of profitability, KRON's ROE is -0.64%, compared to LGND's ROE of -0.16%. Regarding short-term risk, KRON is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs KYMR Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, KYMR has a market cap of 2.03B. Regarding current trading prices, KRON is priced at $0.73, while KYMR trades at $31.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas KYMR's P/E ratio is -10.45. In terms of profitability, KRON's ROE is -0.64%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, KRON is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs BHVN Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BHVN has a market cap of 1.99B. Regarding current trading prices, KRON is priced at $0.73, while BHVN trades at $19.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BHVN's P/E ratio is -2.10. In terms of profitability, KRON's ROE is -0.64%, compared to BHVN's ROE of -2.57%. Regarding short-term risk, KRON is less volatile compared to BHVN. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs HRMY Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, HRMY has a market cap of 1.97B. Regarding current trading prices, KRON is priced at $0.73, while HRMY trades at $34.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas HRMY's P/E ratio is 13.12. In terms of profitability, KRON's ROE is -0.64%, compared to HRMY's ROE of +0.24%. Regarding short-term risk, KRON is less volatile compared to HRMY. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs BLTE Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BLTE has a market cap of 1.94B. Regarding current trading prices, KRON is priced at $0.73, while BLTE trades at $60.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BLTE's P/E ratio is -51.60. In terms of profitability, KRON's ROE is -0.64%, compared to BLTE's ROE of -0.31%. Regarding short-term risk, KRON is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs NAMSW Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, NAMSW has a market cap of 1.90B. Regarding current trading prices, KRON is priced at $0.73, while NAMSW trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas NAMSW's P/E ratio is N/A. In terms of profitability, KRON's ROE is -0.64%, compared to NAMSW's ROE of -0.26%. Regarding short-term risk, KRON is less volatile compared to NAMSW. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.
KRON vs BLU Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, BLU has a market cap of 1.87B. Regarding current trading prices, KRON is priced at $0.73, while BLU trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas BLU's P/E ratio is -20.20. In terms of profitability, KRON's ROE is -0.64%, compared to BLU's ROE of -0.06%. Regarding short-term risk, KRON is more volatile compared to BLU. This indicates potentially higher risk in terms of short-term price fluctuations for KRON.
KRON vs KNSA Comparison
KRON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KRON stands at 44.29M. In comparison, KNSA has a market cap of 1.87B. Regarding current trading prices, KRON is priced at $0.73, while KNSA trades at $25.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KRON currently has a P/E ratio of -0.51, whereas KNSA's P/E ratio is -106.67. In terms of profitability, KRON's ROE is -0.64%, compared to KNSA's ROE of -0.04%. Regarding short-term risk, KRON is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for KRON.